- DOJ seeks immediate asset freeze, receivership against telehealth company Zealthy
- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Brain Cancer Awareness: The Importance of Molecular Testing for Patients with Rare Brain Tumors
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
Can she be any worse than Rochelle Walensky?
CDC pick will find agency at a crossroadsPresident Biden has reportedly selected Mandy Cohen to lead the Centers for Disease Control and Prevention after Rochelle Walensky leaves this month.
Cohen, a former North Carolina health secretary, would inherit the role of CDC director as the agency finds itself under intense scrutiny for its public falterings in responding to COVID-19, especially for how it conveyed new information to the public.
Polls show public trust in the CDC has steadily declined, and congressional Republicans are likely going to question Cohen about the agency’s plans for change.
Walensky launched an overhaul of the CDC at the start of this year, and will leave before it’s finished.
While Walensky was an infectious disease doctor without much government experience, Cohen has plenty of government experience without an infectious disease background — something many outside health experts said they were hoping to see in the next CDC director.
Concerns around COVID-19 have largely faded into the background for many Americans, and experts have said government experience should take priority.
Cohen spent five years as North Carolina’s health secretary, helping the state pass Medicaid expansion and leading it through the height of the COVID-19 pandemic.
The CDC director won’t be a Senate-confirmed position until January 2025, so Cohen could presumably take over fairly quickly once she is formally announced.
Cohen also served in the Centers for Medicare and Medicaid Services during the Obama administration, helping to set up ObamaCare’s insurance exchanges and fix the disastrous rollout of Healthcare.gov, where she worked closely with current White House chief of staff Jeff Zients.
Major priorities for the agency include the reauthorization of a pandemic preparedness measure that expires on Sept. 30, as well as fiscal year 2024 appropriations.
Public health and research advocates have expressed concern that Republicans, angry at the agency for its COVID response, could try to cut funding.
"Major priorities for the agency include the reauthorization of a pandemic preparedness measure that expires on Sept. 30, as well as fiscal year 2024 appropriations."
Translation: they want power, and they want money.
She's a bureaucrat in charge of running a bureaucracy.... does anyone see any real change in this picture?
Why yes, she can be worse than Rochelle Walensky! 😏
From my hero, Alex Berenson:
https://alexberenson.substack.com/p/urgent-joe-biden-is-about-to-pick
URGENT: Joe Biden is about to pick the worst possible person to become the next CDC headAlex Berenson
June 2, 2023I'm not exaggerating. Dr. Mandy Cohen, the likely choice, is a public health Covid authoritarian and former chief of staff for censorer-in-chief Andy Slavitt.
Just what America needs.
Another Covid hysteric running the Centers for Disease Control.
Proving it has learned all the wrong lessons since 2021, the Biden Administration is about to choose Dr. Mandy Cohen to replace Dr. Rochelle Walensky as director of the Centers for Disease Control.
Cohen shares the same health authoritarian impulses as Walensky. She supported mask and vaccine mandates - and lockdowns even in 2021. But she is apparently more bureaucratically competent, and thus more dangerous, than Walensky.
Cohen is also very close to Andy Slavitt, whom I am suing in Berenson v Biden for his efforts to censor me. Her choice suggests Slavitt still has considerable influence in the Biden Administration two years after officially leaving the White House.
Apparently diversity mandates haven’t hit the CDC yet. Cohen is a lot like Walensky, a nice Jewish* doctor** from the Northeastern suburbs with all the right degrees.
(*I can say it, I’m Jewish)
(**The actual expression is “nice Jewish girl” but I don’t want to get in trouble)
Perhaps the biggest difference is that Cohen is less orange. Not figuratively, literally; Walensky’s skin tone occupies an uncanny valley somewhere between North Africa and Malibu Barbie. But I digress.
(Digression continues. What color is that? It’s not beige, it’s not orange, it’s not brown, it’s not white. Seriously, what color? Ecru? But is ecru a color, or just a world for beige at fancy furniture stores?)
I know, I shouldn’t make of Rochelle Walensky’s skin tone when there is SO MUCH ELSE to make fun her over.
Like that time she told Rachel Maddow that “vaccinated people do not carry the virus, don’t get sick.” Oops! Or the press conference where she said she was “scared” of Covid. Profiles In Courage, get me rewrite!
But wait. This piece isn’t about the departing CDC director, it’s about the incoming CDC director. The queen is dead, long live the queen.
Stunningly, despite their vast similarities in professional training and life experience, Cohen and Walensky have tons in common.
They both approached Covid by maximizing hysteria and government overreach. Like Walensky, Cohen loves her some face diapers.
In fact, she loves them more than Walensky. In December 2021, Cohen said that “everyone” needed to keep wearing masks. “Even if you’re vaccinated, you should wear a mask,” she said. Even the CDC had dropped its mask requirements for vaccinated people seven months before.
(No, seriously, she LOVES masks.
ALT: I got Tony Fauci sitting on my face. And he’s delicious!)
Besides pushing lockdowns through March 2021, Cohen also threatened legal action against a school district that wanted to drop quarantines and contact tracing - in September 2021, long after Covid’s lack of risk to school-age children became apparent. She pushed jab mandates for health care workers and explicitly tied loosening restrictions to vaccination levels.
In other words, Cohen has heartily supported every authoritarian measure that the last three years have proven useless. Of course, to the White House, her views are a feature, not a bug. And the Biden Administration seems to believe she will be able to make the CDC even more willing to follow its lead.
“White House officials were drawn to Cohen’s track record of leadership at the federal and state level, said people familiar with the process who spoke on the condition of anonymity,” the Washington Post reported. “That’s a stark contrast to Walensky, who was in her first leadership role in government.”
As Slavitt told the Post: “What the CDC needs now is what Mandy Cohen brings… I’ve worked with her as close as anyone and if she’s the choice, the country is in for a treat.”
Let’s all try not to choke.
Truly cringe-worthy!
Here's a palate-cleanser of sorts - ideas on how to limit the CDC.
https://brownstone.org/articles/the-cdc-as-we-know-it-has-to-go/
... Second, and more fundamentally, I wondered what structural reforms might turn the CDC into the agency that I had imagined before COVID. Here, my mind kept turning to thoughts about an agency that stands out as an example of good government: the National Transportation Safety Board. The NTSB is respected nationwide, and around the globe, for its skill, transparency, and reliability in investigating significant travel accidents, determining their causes, and proposing recommendations for new safety practices and regulations. The NTSB’s work has made enormous contributions to improvements in transportation safety over the years, and its reports can be real page-turners.A critical component to the NTSB’s success is that it has no regulatory authority. In 1967, Congress established it as an independent agency within the Department of Transportation. The idea was that “a single organization with a clearly defined mission could more effectively promote” transportation safety. However, Congress soon recognized that the only way to assure the NTSB’s independence was to move it outside of the DOT, so in 1974 Congress reestablished it as a separate agency.
Agencies charged with regulating transportation, such as the FAA, have to consider economic factors and the promotion of transportation in addition to safety. This cost/benefit responsibility can sometimes leave the FAA vulnerable to regulatory capture, as we saw with the 737-MAX catastrophe. The NTSB’s independence and its lack of regulatory authority, by contrast, give it the freedom to focus on fact-finding and to make recommendations, without being subjected to such pressures.
It would behoove Congress to consider a similar approach to restructuring the CDC. We need a federal public health agency that is just like the NTSB, one that is strictly charged with fact-finding and with making recommendations, but without any regulatory authority of its own. This would require moving the CDC out of HHS. The new CDC would have a limited role of investigating the causes and sources of infectious disease, and to make recommendations for how to address them, but without any regulatory authority that, as we have learned, could subject the agency to political pressure and regulatory capture.
Consider the fact that we still do not know for certain where COVID originated. Was it a lab leak, or the result of zoonosis? The NIH, which funded risky gain of function research in Wuhan, is also part of HHS. Had the CDC been taken out of HHS and given independent investigative powers, including the power to audit HHS’s research funding practices, there is a fair chance that we would know the answer to that. We would also likely have a series of dispassionate recommendations on what to do about preventing future occurrences.
If COVID proved anything, it is that we desperately need a federal agency like this. If Congress is serious about restoring trust in public health, it would do well to consider such a reform.
Brant C. Hadaway is a seasoned, bilingual (English/Czech) attorney focusing his practice on international commercial disputes, contracts, and regulatory compliance on behalf of foreign and domestic clients in the U.S. and abroad.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














